American Marconi Wireless News

MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics

GENEVA, SWITZERLAND / ACCESS Newswire / December 23, 2025 / MindMaze Therapeutics Holding SA (SIX:MMTX ) (MindMaze Therapeutics or the Company), a commercial-stage company delivering evidence-based, precision digital treatments for neurological diseases, today outlined the evolution of its global reimbursement strategy to enable scalable patient access and sustainable commercial growth for next-generation neurotherapeutics.

Spotify says piracy activists hacked its music catalogue

Music streaming service Spotify said Monday it had disabled accounts from a piracy activist hacker group that claimed to have "backed up" millions of Spotify's music files and metadata.

Last of kidnapped Nigerian pupils handed over, government says

Some 130 Nigerian Catholic school pupils were handed over to state authorities Monday, a day after the government said it had secured their release a month after one of the country's worst mass abductions.

Italy fines Apple nearly 100 mn euros over app privacy feature

Italy's competition authority said Monday it had fined the US tech giant Apple 98 million euros ($115 million) for allegedly abusing its dominant position in the mobile app market.

German Christmas markets hit by flood of fake news

Security has been tightened at German Christmas markets after recent deadly attacks. But if some online videos were to be believed, they've become barbed-wire fortresses guarded by armoured personnel carriers.

Alleged Bondi shooters conducted 'tactical' training in countryside, Australian police say

The two suspects in a deadly mass shooting at Australia's Bondi Beach carried out "tactical" training in the countryside, police alleged Monday, as Prime Minister Anthony Albanese apologised to the country's Jewish community and vowed tougher laws against extremism.

Jailed Malaysian ex-PM Najib loses bid for house arrest

Former Malaysian leader Najib Razak lost a bid Monday to have his jail term changed to house arrest, a setback ahead of a separate verdict this week tied to the country's 1MDB scandal.

Australian state pushes tough gun laws, 'terror symbols' ban after shooting

Australia's most populous state pushed ahead Monday with what it said were the country's strictest gun laws and a ban on displaying "terrorist" symbols after two gunmen killed 15 people celebrating a Jewish festival in Sydney last week.

Castle Connolly Names Dr. Meegan Gruber, MD, PhD a 2026 Exceptional Woman in Medicine; Recognition to Be Featured in New York Magazine

Board-certified plastic surgeon and surgeon-scientist honored for clinical excellence, leadership, and commitment to patient education.

Planning Time Off in 2026: Dr. Meegan Gruber, MD, PhD Releases a Recovery-Logistics Guide for Busy Professionals Considering Plastic Surgery

New "Recovery Logistics" checklist helps patients coordinate work, childcare, travel, and follow-up support-before they choose a surgery date.

How to Choose a Plastic Surgeon in 2026: Dr. Meegan Gruber, MD, PhD Releases a Tampa Bay Patient Safety Checklist

Board-certified plastic surgeon shares a practical, question-based guide to help patients verify credentials, facility standards, and anesthesia planning before elective cosmetic surgery.

Facelift + Eyelid Surgery in Tampa: Gruber Plastic Surgery Shares 2025 Planning Insights on Natural Results and Popular Procedure Pairings

ASPS trend reporting highlights facelift combined with eyelid surgery as a leading 2025 combination; national procedure volumes reinforce growing demand for comprehensive facial rejuvenation planning.

Forte Group Receives BC Liquor Co-Packing Licence, Expanding Beverage Alcohol and Zero-Proof Manufacturing Capabilities at Its British Columbia Beverage Manufacturing Facility

News Release Highlights:Forte Group's wholly-owned subsidiary, Naturo Group Enterprises Inc., has received a Liquor Co-Packing Licence, authorizing the Company to pursue beverage alcohol co-packing operations within a designated 10,000-square-foot licensed area of its 40,000-square-foot manufacturing facility in Bridesville, British Columbia, expanding the Company's permitted manufacturing capabilities.The licence positions Forte Group to evaluate and pursue future contract manufacturing opportunities with licensed beverage alcohol brands, as well as non-alcoholic "mock" or zero-proof liquor-style beverages, leveraging its broader production platform to support potential new revenue verticals and increased facility utilization.In parallel, the Company is evaluating the pursuit of an additional liquor licence that would permit direct sales to provincial liquor distribution authorities, in response to advanced discussions with an arm's-length strategic third party regarding a potential alcohol co-manufacturing relationship.

CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD

SAN DIEGO, CA / ACCESS Newswire / December 22, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today applauds President Trump's recent Executive Order (the "Order") to improve cannabidiol research to better inform patients and doctors. The Order directs agencies within the Department of Health and Human Services to allow Americans to benefit from access to appropriate full-spectrum CBD products based on research methods and models utilizing real-world evidence. Hemp-derived cannabinoid products have potential to improve patient symptoms for common ailments including pain, sleep and anxiety. This Order paves the way for hemp-derived cannabinoid products, primarily containing CBD, to be available under a regulated environment that would vastly improve product quality, safety and consumer confidence.

Trump’s Marijuana Schedule III Order Launches a Federally Regulated Healthcare Sector

MMJ's position is further fortified by its FDA Orphan Drug Designations for the treatment of Huntington's Disease. These designations are awarded to drugs intended for the safe and effective treatment of rare diseases and provide MMJ with critical incentives, including: Seven Years of Market Exclusivity: Protecting MMJ's innovations upon FDA approval. Tax Credits: Applied to qualified clinical testing expenses. Waived FDA Fees: Significantly reducing the capital barriers to drug commercialization. Accelerated Review: Streamlining the path to provide relief to patients with unmet medical needs.

Maison Solutions Reports Second Quarter and Six Month 2026 Financial Results

MONTEREY PARK, CA / ACCESS Newswire / December 22, 2025 / Maison Solutions Inc. (NASDAQ:MSS) ("Maison Solutions" or the "Company"), a U.S.-based specialty grocery retailer offering traditional Asian and international food and merchandise, today announced financial results for the second quarter and six months ended October 31, 2025.

Mother-Daughter Duo Launch Cultural Brand Bridging Argentina and the U.S. Through Mate Tradition

MIAMI, FL / ACCESS Newswire / December 22, 2025 / A mother and daughter living thousands of miles apart are turning cultural tradition into connection-and connection into a fast-growing brand that's captivating audiences across the United States. Veronica Piacente, based in Argentina, and her daughter Delfina Garcia Piacente, based in the U.S., are the co-founders of Huellas Argentinas, an artisan brand dedicated to sharing the heritage of mate culture through beautifully designed products that carry meaning, identity, and warmth.

Natural Products Expo West Introduces Inaugural CPG Innovation Summit for 2026 Edition

New one-day event to unite brands, investors and industry leaders and forge the future of consumer-packaged goods.

Sannabis S.A.S., a Colombia Licensed Cannabis Operator, Addresses U.S. Marijuana Rescheduling and Potential Implications for International Medical Cannabis Travel and Trade

Potential Schedule III Status Could Improve Legal Clarity for Patients Traveling from Colombia to the United States with Prescribed Medical Cannabis

Mosaic Announces Agreement to Sell Mosaic Potash Carlsbad Inc to International Minerals Carlsbad, LLC

TAMPA, FL / ACCESS Newswire / December 22, 2025 / The Mosaic Company (NYSE:MOS) today announced that it has signed a definitive agreement to sell Mosaic Potash Carlsbad, Inc., including the operations, assets and liabilities of the Mosaic mine in Carlsbad, New Mexico to International Minerals Carlsbad, LLC for $30 million. The transaction includes an initial cash purchase price of $20 million, subject to customary adjustments at closing, and deferred cash consideration totaling $10 million payable in three equal annual installments beginning in 2029. Additionally, International Minerals Carlsbad, LLC will assume responsibility for the asset retirement obligations associated with the Carlsbad operations. Mosaic expects to close the transaction in the first half of 2026 and record a non-cash asset impairment in the fourth quarter of 2025.

Informa Markets Health and Nutrition Brands Highlight Strategic Partnerships, Championing Voices Across Food, Nutrition, Health and Wellness

PHOENIX, AZ / ACCESS Newswire / December 22, 2025 / Informa Markets Health and Nutrition portfolio serves as a premier global platform for the health, wellness and nutrition industries, specializing in events and solutions to bring together professionals, suppliers, manufacturers and buyers to create opportunities for meaningful connections and business growth.

FDA Officially Confirms Kava is a Food Under Federal Law

U.S. Food and Drug Administration (FDA), After Reviewing Historical Use and Modern Safety Evidence, Officially Confirms Kava is a Food Under Federal Law

World Renowned Law Firm Grant & Eisenhofer Files Class Action Lawsuit Against Canadian Banks CIBC and RBC Alleging Illegal Stock Market Manipulation of Quantum BioPharma Shares

TORONTO, ONTARIO / ACCESS Newswire / December 22, 2025 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma"),understands that Quantum BioPharma shareholder Paul Durkacz has filed a class action lawsuit alleging that investors in Quantum BioPharma were the victims of stock manipulation. The suit alleges that between January 6, 2021, and October 15, 2025, shareholders who sold securities of Quantum Biopharma Ltd., formerly known as FSD Pharma Inc., were significantly and materially harmed.

The Alkaline Water Company Receives SEC Qualification of Tier 1 Regulation A Offering of Up to $10 Million

GLENDALE, AZ / ACCESS Newswire / December 22, 2025 / The Alkaline Water Company, Inc. (OTCID:WTER) (the "Company") today announced that the U.S. Securities and Exchange Commission ("SEC") has qualified the Company's Tier 1 Regulation A offering statement on Form 1-A, enabling the Company to proceed with a public offering of its common stock.

Ovation Science Sees Expanded Opportunities for Its Topical Products Following U.S. Cannabis Rescheduling

VANCOUVER, BC AND LAS VEGAS, NV / ACCESS Newswire / December 22, 2025 / Ovation Science Inc. (CSE:OVAT)(OTC PINK:OVATF) ("Ovation" or the "Company") welcomes the recent U.S. rescheduling of cannabis and the potential introduction of a Medicare program that could allow patient access to much-needed, potentially life-changing CBD therapies, including topical formulations. Ovation's science-based topical / transdermal cannabis products are supported by clinical evidence and demonstrated commercial success through its licensee network.

DealFlow Discovery Conference Announces Panel on Microcap Deal Trends and Regulation for 2026, Featuring Richard Anslow of Ellenoff Grossman & Schole

Industry experts to examine 2025 deal data, evolving regulatory pressures, and capital formation strategies shaping the microcap market

Medicus Pharma Ltd. Announces Engagement With Reliant AI to Develop Artificial Intelligence (AI) Driven Clinical Data Analytics Platform

The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute urinary retention (AURr) and high CV risk prostate cancer collectively representing ~$6 billion in potential market opportunity

1933 Industries Issues Final Reminder to 2024 Debenture Holders: December 22 Is the Deadline to Convert

VANCOUVER, BC / ACCESS Newswire / December 22, 2025 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTCID:TGIFF) issues a final reminder to holders of its unsecured convertible debentures issued in 2024 (the "2024 Debentures") that today, December 22, 2025, is the final day to submit conversion instructions in accordance with the terms of the debenture agreement.

Brenmiller Energy CEO Avi Brenmiller Issues Year-End Letter to Shareholders

Solid foundation for focused growth in 2026103 MWh in cumulative projects deployed and a multimillion dollar pipeline of commercial opportunitiesSmart capital moving into TES industry

1933 Industries Achieves Positive Income in Q1 2026, Marking Third Consecutive Profitable Quarter

VANCOUVER, BC / ACCESS Newswire / December 22, 2025 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTCID:TGIFF), a Nevada-focused cannabis cultivator and producer, is pleased to announce its first quarter financial results ("Q1 2026") for the three months ended October 31, 2025 and 2024. All amounts expressed are in Canadian dollars.

Black Book Poll: "Governed AI" Emerges as the Deciding Factor in 2026 NHS Procurement

Respondents report approvals and evaluation readiness are now the bottlenecks driving demand for reusable safety artefacts, evidence repeatability and lifecycle controls.

Hemogenyx Pharmaceuticals PLC Announces Update on Admission of Shares

LONDON, UK / ACCESS Newswire / December 22, 2025 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, provides an update to the admission of new ordinary shares as announced on 18 December 2025.

RBGPF	-19.57%	69	$
RYCEF	-3.69%	16.01	$
GSK	0.59%	52.37	$
CMSC	0.09%	22.85	$
RELX	-0.12%	33.82	$
RIO	-2.42%	85.65	$
AZN	0.27%	188.93	$
NGG	-2.19%	85.53	$
BTI	1.07%	58.72	$
BCE	-0.08%	25.73	$
JRI	-1.34%	12.16	$
CMSD	0.04%	22.9	$
VOD	0.35%	14.42	$
BCC	-2.83%	69.86	$
BP	2.73%	45.86	$

American Marconi Wireless News - Boulevard (English)

Featured

Three charged with sneaking Nvidia AI chips from US into China

InterContinental Hotels Group PLC Announces Transaction in Own Shares - March 20

Last news